Accolade Interest Expense 2011-2026 | ACCD

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Accolade

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
9.93 M	-15 K	-133 K	-147 K	-107 K	-90 K	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
9.93 M	-147 K	1.57 M

Quarterly Interest Expense Accolade

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-69 K	-103 K	94 K	-69 K	-103 K	94 K	-	9.28 M	753 K	390 K	-	201 K	-130 K	-50 K	-	25 K	-19 K	-44 K	-55 K	-42 K	-42 K	-104 K	-15 K	-18 K	-46 K	-34 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
9.28 M	-130 K	430 K

Interest Expense of other stocks in the Health information services industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Cerner Corporation CERN	43.5 M	-	-	$ 27.9 B	USA
Evolent Health EVH	249 K	$ 4.76	-0.83 %	$ 544 M	USA
HealthEquity HQY	12.1 M	$ 86.35	-2.26 %	$ 7.44 B	USA
Change Healthcare CHNG	234 M	-	-	$ 9.03 B	USA
Computer Programs and Systems CPSI	-4.65 M	-	4.4 %	$ 133 M	USA
Covetrus CVET	32 M	-	-	$ 2.94 B	USA
iCAD ICAD	-49 K	-	-	$ 102 M	USA
GoodRx Holdings GDRX	718 K	$ 2.71	2.27 %	$ 966 M	USA
Akerna Corp. KERN	446 K	-	-	$ 161 M	USA
Allscripts Healthcare Solutions MDRX	15 M	-	-10.39 %	$ 886 M	USA
10x Genomics TXG	1.03 M	$ 32.2	11.65 %	$ 4.02 B	USA
MTBC MTBC	-265 K	-	-0.58 %	$ 51.7 M	USA
1Life Healthcare ONEM	-11.7 M	-	-	$ 3.37 B	USA
NextGen Healthcare NXGN	6.3 M	-	-	$ 1.6 B	USA
Premier PINC	102 M	-	-	$ 2.33 B	USA
OptimizeRx Corporation OPRX	1.45 M	$ 5.39	3.06 %	$ 100 M	USA
Schrödinger SDGR	16.4 M	$ 15.03	4.01 %	$ 1.1 B	USA
Phreesia PHR	2.95 M	$ 9.33	2.98 %	$ 557 M	USA
Teladoc Health TDOC	10.4 M	$ 7.65	4.22 %	$ 1.35 B	USA
Signify Health SGFY	20.6 M	-	-0.02 %	$ 7.21 B	USA
Streamline Health Solutions STRM	-2 K	-	-	$ 21.4 M	USA
NantHealth NH	-2.65 M	-	-46.64 %	$ 10.4 M	USA
SCWorx Corp. WORX	279 K	-	-	$ 7.71 M	USA
American Well Corporation AMWL	5.17 M	$ 9.08	-0.32 %	$ 146 M	USA
Tabula Rasa HealthCare TRHC	1.06 M	-	-	$ 255 M	USA
HealthStream HSTM	-358 K	$ 26.25	0.46 %	$ 788 M	USA
Omnicell OMCL	-270 K	$ 39.22	3.67 %	$ 1.8 B	USA
Progyny PGNY	2.63 M	$ 26.98	1.3 %	$ 2.3 B	USA
So-Young International SY	12.9 M	$ 1.85	-0.81 %	$ 144 M	China
Veeva Systems VEEV	278 M	$ 164.31	2.99 %	$ 26.9 B	USA
Zhongchao ZCMD	79.4 K	$ 0.64	-0.97 %	$ 2.19 M	China